Literature DB >> 33740976

Tooth mousse containing casein phosphopeptide-amorphous calcium phosphate prevents biofilm formation of Streptococcus mutans.

Ronit Vogt Sionov1, Danae Tsavdaridou2,3,4, Muna Aqawi2, Batya Zaks2, Doron Steinberg2, Miriam Shalish4.   

Abstract

BACKGROUND: Streptococcus mutans is a common cariogenic bacterium in the oral cavity involved in plaque formation. Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) has been introduced into tooth mousse to encourage remineralization of dental enamel. The aim of this research was to study the effect of tooth mousse containing CPP-ACP (GC Tooth Mousse®) or CPP-ACP with 0.2% fluoride (CPP-ACPF; GC Tooth Mousse Plus®; GCP) on S. mutans planktonic growth and biofilm formation.
METHODS: S. mutans was cultivated in the presence of different dilutions of the tooth mousse containing CPP-ACP or CPP-ACPF, and the planktonic growth was determined by ATP viability assay and counting colony-forming units (CFUs). The resulting biofilms were examined by crystal violet staining, MTT metabolic assay, confocal laser scanning microscopy (CLSM), and scanning electron microscope (SEM).
RESULTS: The CPP-ACP tooth mousse (GC) at a dilution of 5-50 mg/ml (0.5-5%) did not inhibit planktonic growth, and even increased the ATP content and the number of viable bacteria after a 24 h incubation. The same was observed for the CPP-ACPF tooth mousse (GCP), except for the higher concentrations (25 and 50 mg/ml) that led to a drop in the bacterial count. Importantly, both compounds significantly decreased S. mutans biofilm formation at dilutions as low as 1.5-3 mg/ml. 12.5 mg/ml GC and 6.25 mg/ml GCP inhibited biofilm formation by 90% after 4 h. After 24 h, the MBIC90 was 6.25 mg/ml for both. CLSM images confirmed the strong inhibitory effect GC and GCP had on biofilm formation when using 5 mg/ml tooth mousse. SEM images of those bacteria that managed to form biofilm in the presence of 5 mg/ml tooth mousse, showed alterations in the bacterial morphology, where the streptococci appear 25-30% shorter on the average than the control bacteria.
CONCLUSION: Our data show that the tooth mousse containing CPP-ACP reduces biofilm formation of the cariogenic bacterium S. mutans without killing the bacteria. The use of natural substances which inhibit biofilm development without killing the bacteria, has therapeutic benefits, especially in orthodontic pediatric patients.

Entities:  

Keywords:  Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP); Dental caries; GC Tooth Mousse®; Oral biofilm; Streptococcus mutans

Year:  2021        PMID: 33740976      PMCID: PMC7980609          DOI: 10.1186/s12903-021-01502-6

Source DB:  PubMed          Journal:  BMC Oral Health        ISSN: 1472-6831            Impact factor:   2.757


  41 in total

1.  CPP-ACP Promotes SnF2 Efficacy in a Polymicrobial Caries Model.

Authors:  S G Dashper; P Shen; C P C Sim; S W Liu; C A Butler; H L Mitchell; T D'Cruze; Y Yuan; B Hoffmann; G D Walker; D V Catmull; C Reynolds; E C Reynolds
Journal:  J Dent Res       Date:  2018-11-04       Impact factor: 6.116

2.  Increased remineralization of tooth enamel by milk containing added casein phosphopeptide-amorphous calcium phosphate.

Authors:  Glenn Walker; Fan Cai; Peiyan Shen; Coralie Reynolds; Brent Ward; Christopher Fone; Shuji Honda; Megumi Koganei; Munehiro Oda; Eric Reynolds
Journal:  J Dairy Res       Date:  2006-02       Impact factor: 1.904

3.  Remineralization effect of CPP-ACP and fluoride for white spot lesions in vitro.

Authors:  Gustavo M S Oliveira; André V Ritter; Harald O Heymann; Edward Swift; Terry Donovan; Guy Brock; Tim Wright
Journal:  J Dent       Date:  2014-09-23       Impact factor: 4.379

4.  Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions.

Authors:  E C Reynolds
Journal:  J Dent Res       Date:  1997-09       Impact factor: 6.116

5.  Remineralization of enamel subsurface lesions in situ by sugar-free lozenges containing casein phosphopeptide-amorphous calcium phosphate.

Authors:  F Cai; P Shen; M V Morgan; E C Reynolds
Journal:  Aust Dent J       Date:  2003-12       Impact factor: 2.291

6.  Differential gene expression profiling of Streptococcus mutans cultured under biofilm and planktonic conditions.

Authors:  Moshe Shemesh; Avshalom Tam; Doron Steinberg
Journal:  Microbiology       Date:  2007-05       Impact factor: 2.777

Review 7.  Orthodontic treatment with fixed appliances and biofilm formation--a potential public health threat?

Authors:  Yijin Ren; Marije A Jongsma; Li Mei; Henny C van der Mei; Henk J Busscher
Journal:  Clin Oral Investig       Date:  2014-04-13       Impact factor: 3.573

8.  Thiazolidinedione-8 Alters Symbiotic Relationship in C. albicans-S. mutans Dual Species Biofilm.

Authors:  Mark Feldman; Isaac Ginsburg; Abed Al-Quntar; Doron Steinberg
Journal:  Front Microbiol       Date:  2016-02-10       Impact factor: 5.640

9.  Corrigendum to "A 12-Week Assessment of the Treatment of White Spot Lesions with CPP-ACP Paste and/or Fluoride Varnish".

Authors:  Zeynep Aslı Güçlü; Alev Alaçam; Nichola Jayne Coleman
Journal:  Biomed Res Int       Date:  2018-12-24       Impact factor: 3.411

10.  Polyphenols Inhibit Candida albicans and Streptococcus mutans Biofilm Formation.

Authors:  Yosi Farkash; Mark Feldman; Isaac Ginsburg; Doron Steinberg; Miriam Shalish
Journal:  Dent J (Basel)       Date:  2019-04-11
View more
  2 in total

1.  Targeting the Achilles' Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide.

Authors:  Ronit Vogt Sionov; Shreya Banerjee; Sergei Bogomolov; Reem Smoum; Raphael Mechoulam; Doron Steinberg
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

2.  Voice Prosthesis Coated with Sustained Release Varnish Containing Clotrimazole Shows Long-Term Protection against Candida albicans: An In Vitro Study.

Authors:  Ronit Vogt Sionov; Irith Gati; David Kirmayer; Michael Friedman; Doron Steinberg; Menachem Gross
Journal:  Molecules       Date:  2021-09-05       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.